Tri Act 2mg/500mg/15mg Tablet SR
Marketer
Edinburgh Pharmaceuticals
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Tri Act 2mg/500mg/15mg Tablet SR
Metformin/Glimepiride/Pioglitazone extended-release tablets (2mg/500mg/15mg) are a combined medication for managing blood glucose. This treatment, used alongside diet and exercise, enhances glycemic control in adults with type 2 diabetes. It improves insulin effectiveness, reducing blood sugar. Dosage and frequency should strictly follow your physician's instructions. Take with food to prevent digestive discomfort. Missed doses should be taken promptly unless nearing the next scheduled dose; avoid doubling the dose. Overdosage can cause hypoglycemia (low blood sugar). Concurrent use with other diabetes medications, alcohol, or skipped meals may increase hypoglycemia risk; regular blood glucose monitoring is essential. Common side effects include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to commencing treatment, disclose any kidney, liver, or heart conditions to your doctor. Pregnant or lactating individuals require medical consultation before use. Kidney function tests will be assessed before prescription. Limit alcohol consumption due to potential side effect exacerbation.
Primary Ingredients of Tri Act 2mg/500mg/15mg Tablet SR
No text provided. Please provide the text you wish me to rephrase.
Uses of Tri Act 2mg/500mg/15mg Tablet SR
Managing type 2 diabetes
Major Benefits of Tri Act 2mg/500mg/15mg Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Tri Act 2mg/500mg/15mg Tablet SR whole; do not crush, chew, or divide it. Administer this medication with food.
Common Side effects of Tri Act 2mg/500mg/15mg Tablet SR:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Tri Act 2mg/500mg/15mg Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Tri Act 2mg/500mg/15mg Tablet SR whole; avoid crushing, chewing, or breaking it. Administer this medication with a meal.
How Tri Act 2mg/500mg/15mg Tablet SR works:
Tri Act 2mg/500mg/15mg Extended-Release Tablets combine glimepiride, metformin, and pioglitazone—three distinct antidiabetic agents—to enhance blood sugar management when monotherapy or dual therapy proves insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thus reducing blood glucose levels. Metformin, a biguanide, acts through multiple pathways: decreasing hepatic glucose production, slowing intestinal glucose absorption, and improving insulin responsiveness. Pioglitazone, a thiazolidinedione, complements this action by further augmenting insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol alongside Tri Act 2mg/500mg/15mg SR tablets poses a safety risk.
PregnancyCONSULT YOUR DOCTOR
Using Tri Act 2mg/500mg/15mg SR tablets during pregnancy might pose risks. While human data is scarce, animal research indicates potential harm to the unborn child. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Use of Tri Act 2mg/500mg/15mg SR tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Patients with kidney impairment should use Tri Act 2mg/500mg/15mg SR tablets cautiously, potentially requiring dosage modification. Physician consultation is essential. Tri Act 2mg/500mg/15mg SR tablets are contraindicated in individuals with severe kidney disease. Regular kidney function monitoring is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use Tri Act 2mg/500mg/15mg SR tablets cautiously, potentially requiring dosage modification. Medical advice is necessary. Tri Act 2mg/500mg/15mg SR tablets are contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Tri Act 2mg/500mg/15mg Tablet SR :
Should you forget to take a Tri Act 2mg/500mg/15mg Tablet SR, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosage regimen. Avoid taking a double dose.
Facts to Know About Tri Act 2mg/500mg/15mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently